Engaging with your supply chain to reduce scope 3 emissions

AstraZeneca is a global science-led biopharmaceutical company that has been disclosing through CDP for over a decade and has been ranked on the CDP A List for both climate change and water security for six consecutive years.

Since 2015, AstraZeneca has delivered a 59% reduction in their Scope 1 and 2 emissions and in October 2021, AstraZeneca became one of the first companies worldwide to have its emissions reductions targets verified by the Science Based Targets initiative’s new Net-Zero Standard.

AstraZeneca has set an ambitious target to halve their entire global and complex value chain footprint (from 2015 baseline) by 2030 leading to a 90% reduction by 2045 (from 2019 baseline).

In this session, Rob will discuss emissions reduction levers companies can employ to reduce emissions across scope 3 as well as unlocking innovations and collaborations.